Arbutus Biopharma

Y! Tekmira Pharmaceuticals Homepage Tekmira Clinical Trials TKM.TO (quote) Potential Catalysts by Gobigred Ebola Summary Updated catalysts 2016 JPM Corporate update and goals

ABUS / Message Board

BOARD

GROUPS

Written By On Topic Only -- All Messages

Hide Replies

Keyword
Subject

Between			and
Rec'd By

Authored By
Minimum Recs

MSG #	SUBJECT	TYPE	AUTHOR	SENTIMENT	RECS	DATE POSTED
34963	Re: BNT171 first candidate from BioNTech/Genevant collaboration	GN	Steve_382		0	11/22/2020 11:16:38 AM

34962	Re: BNT171 first candidate from BioNTech/Genevant collaboration	GN	liuyiiv		0	11/22/2020 10:37:33 AM

34961	BNT171 first candidate from BioNTech/Genevant collaboration	GN	liuyiiv		2	11/21/2020 3:39:57 PM

34960	Re: Arbutus Announces Additional Robust HBsAg Decline Data with AB-729 in Chronic Hepatitis B Subjects	GN	Patc		0	11/17/2020 8:11:16 AM

34959	Arbutus Announces Additional Robust HBsAg Decline Data with AB-729 in Chronic Hepatitis B Subjects	GN	Papichi78	Buy	2	11/16/2020 8:00:07 AM

34958	Conclusion slide	GN	Papichi78	Buy	1	11/15/2020 4:13:09 PM

34957	Arbutus Announces Presentation of Phase 1a/1b Clinical Trial Results for AB-729 in Chronic Hepatitis B Subjects at The Liver Meeting Digital Experience™, The American Association for the Study of Liver Diseases Meeting	GN	Papichi78	Buy	1	11/15/2020 3:39:17 PM

34956	Dirk on Abus after the Pfizer/Bntx covid vaccine news	GN	soyano		1	11/9/2020 8:47:45 PM

34955	Genevant licenses LNPs to Gritstone	GN	gobigred		3	10/29/2020 2:51:55 PM

34954	Beam Therapeutics using LNP to deliver CRISPR PCSK9 to liver	GN	liuyiiv		4	10/27/2020 8:29:29 PM

BOARDS Sign In for Filters